PROLONGED-RELEASE MELATONIN FOR INSOMNIA – AN OPEN-LABEL LONG-TERM STUDY OF EFFICACY, SAFETY, AND WITHDRAWAL

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

Patrick Lemoine1, Doron Garfinkel2, Moshe Laudon3, Tali Nir3, Nava Zisapel3,41The Clinique Lyon-Lumière, Meyzieu, France; 2Geriatric-Palliative Department, Shoham Geriatric Medical Center, Pardes Hanna, Israel; 3Neurim Pharmaceuticals Ltd, Tel-Aviv, Israel; 4Department of Neurobiology Faculty of Life Sciences, Tel Aviv University, Tel Av

read more



Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

Migraine is the most common neurological disorder, and contributes to disability and large healthcare costs in the United States and the world.The treatment of migraine until recently has focused on medications, both abortive and prophylactic, but treatment tekoparta of chronic migraine has been revolutionized with the introduction of botulinum tox

read more